
New research finds foreign-born black women aren’t benefiting from public health advances in HIV at the same rates.

New research finds foreign-born black women aren’t benefiting from public health advances in HIV at the same rates.

The community-based program intent on improving black men's blood pressure care will revamp its practice headed into 2019.

The FDA has approved Shire’s prucalopride (Motegrity) for the treatment of chronic idiopathic constipation (CIC).

Mechanistic studies examining human milk bioactives and their impact on lung health and asthma development are beginning to emerge. What more needs to be found?

Over the past 5 years, the US healthcare system has gradually become a victim of its own success.

A form of artificial intelligence could 1 day be a diagnostic tool for disorders like epilepsy.

Preventative medicine dominated the focus for C difficile treatment; however, a new reactive therapy also emerged.

New research helps explain why young gay black men have much higher rates of HIV despite also having much lower rates of risky behavior.

Children often develop food allergies prior to developing asthma, and the former condition is associated with a greater risk of the latter condition in later life.

After successful trials in animal models, researchers say they will soon launch clinical trials of an eye drop to treat age-related macular degeneration.

New research shows the majority of young people get HCV through drug use, but also finds liver disease progresses at the same pace regardless of age at diagnosis.

The therapy is indicated for ITP patients aged 1 year and older who have been diagnosed for at least 6 months, and have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.

The FDA has approved romiplostim for the treatment of pediatric patients with immune thrombocytopenia (ITP).

This past year came with a multitude of new FDA approvals for antiretroviral therapies as well as research highlighting HIV and various comorbidities.

A new imaging technique may provide improvements to the diagnosis and treatment of diseases like age-related macular degeneration (AMD).

Children with asthma were less likely to have an ER visit if their families received greater SNAP benefits than if their family received a smaller benefit.

FeNO monitoring has been recommended as an assessment tool to determine whether patients who are on high-dose inhaled corticosteroids or low-dose oral corticosteroids have residual inflammation.

Living in rural areas and coal burning for heat were found to be risk factors for developing COPD.

Highly-purified cannabidiol (CBD) marketed as Epidiolex can lower the chances of seizures in adults and children with epilepsy.

What if insights from population data were able to help doctors predict a potential diagnosis months or even years earlier and be used to monitor these patients after a diagnosis is made?

Molecular testing for HCV and other infectious diseases can be done successfully in a point-of-care setting, but a new study says participation rates might be driven down in HIV is mentioned.

Patients with epilepsy who live in high crime areas of Chicago had 3 times the rate of seizures as those in low crime neighborhoods.

New research finds posttraumatic growth is an important positive factor in life satisfaction for patients with HIV, even after controlling for the negative consequences of stigma and disclosure regret.

The ethically dubious physician says he has no regrets. Here’s why.

In 2018, investigators confirmed that one of the staple symptoms of multiple sclerosis—white matter demyelination—isn't always consistent.

The FDA has approved Atlantic Therapeutics’ INNOVO, the first non-invasive therapy device for stress urinary incontinence.

The guidance touches on hand hygiene, airway management, environmental disinfection, and IV drug injection recommendations.

The study found that some C difficile spores can survive the commercial laundry process and may contribute to C difficile outbreaks.

Investigators examined the latest clinical guideline updates for C difficile testing.

In a clinical trial, the reSET-O app increased retention in an outpatient opioid use disorder treatment program.